| Primary |
| Drug Use For Unknown Indication |
29.3% |
| Hormone Replacement Therapy |
27.6% |
| Menopausal Symptoms |
8.6% |
| Depression |
6.0% |
| Migraine |
6.0% |
| Anxiety |
2.6% |
| Hormone Therapy |
2.6% |
| Hypercholesterolaemia |
2.6% |
| Postmenopause |
2.6% |
| Burn Oesophageal |
1.7% |
| Menopausal Disorder |
1.7% |
| Menopause |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Gastritis |
0.9% |
| Headache |
0.9% |
| Hyperlipidaemia |
0.9% |
| Hypertension |
0.9% |
| Hypothyroidism |
0.9% |
| Pulmonary Embolism |
0.9% |
|
| Breast Cancer |
12.2% |
| Pulmonary Embolism |
12.2% |
| Cerebral Infarction |
6.1% |
| Colitis Ischaemic |
6.1% |
| Endometrial Cancer |
6.1% |
| Peripheral Embolism |
6.1% |
| Speech Disorder |
6.1% |
| Cerebral Venous Thrombosis |
4.1% |
| Cervical Polyp |
4.1% |
| Cholecystitis |
4.1% |
| Cholelithiasis |
4.1% |
| Deep Vein Thrombosis |
4.1% |
| Hepatitis |
4.1% |
| Metrorrhagia |
4.1% |
| Pain In Extremity |
4.1% |
| Respiratory Disorder |
4.1% |
| Cerebellar Infarction |
2.0% |
| Cerebrovascular Accident |
2.0% |
| Cold Sweat |
2.0% |
| Medication Error |
2.0% |
|
| Secondary |
| Hormone Replacement Therapy |
51.0% |
| Rheumatoid Arthritis |
9.0% |
| Menopausal Symptoms |
5.0% |
| Pulmonary Embolism |
5.0% |
| Menopause |
4.0% |
| Oestrogen Deficiency |
4.0% |
| Hypertension |
3.0% |
| Weight Control |
3.0% |
| Depression |
2.0% |
| Onychomycosis |
2.0% |
| Osteoporosis Prophylaxis |
2.0% |
| Pain |
2.0% |
| Headache |
1.0% |
| Hormone Therapy |
1.0% |
| Hyperlipidaemia |
1.0% |
| Hypothyroidism |
1.0% |
| Insomnia |
1.0% |
| Migraine |
1.0% |
| Plasma Cell Myeloma |
1.0% |
| Product Used For Unknown Indication |
1.0% |
|
| Breast Cancer Female |
20.8% |
| Breast Cancer |
16.7% |
| Aplastic Anaemia |
8.3% |
| Invasive Ductal Breast Carcinoma |
8.3% |
| Pain In Extremity |
8.3% |
| Renal Neoplasm |
8.3% |
| Feeling Abnormal |
4.2% |
| Hepatitis |
4.2% |
| Parosmia |
4.2% |
| Pulmonary Embolism |
4.2% |
| Thrombosis |
4.2% |
| Vaginal Haemorrhage |
4.2% |
| Vomiting |
4.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
13.3% |
| Rheumatoid Arthritis |
11.5% |
| Hypertension |
9.6% |
| Hormone Replacement Therapy |
7.8% |
| Osteoporosis |
7.8% |
| Essential Hypertension |
6.0% |
| Drug Use For Unknown Indication |
5.5% |
| Blood Corticotrophin Decreased |
4.1% |
| Diabetes Mellitus |
3.2% |
| Menopause |
3.2% |
| Neuralgia |
3.2% |
| Ovarian Disorder |
3.2% |
| Antibiotic Therapy |
2.8% |
| Blood Follicle Stimulating Hormone Decreased |
2.8% |
| Blood Luteinising Hormone Decreased |
2.8% |
| Blood Thyroid Stimulating Hormone Decreased |
2.8% |
| Cardiospasm |
2.8% |
| Hypogonadism Female |
2.8% |
| Oedema |
2.8% |
| Asthma |
2.3% |
|
| Arthropathy |
7.8% |
| Vomiting |
7.8% |
| Adrenocortical Insufficiency Acute |
5.9% |
| Convulsion |
5.9% |
| Gastric Polyps |
5.9% |
| Granulomatosis With Polyangiitis |
5.9% |
| Myelofibrosis |
5.9% |
| Oesophageal Spasm |
5.9% |
| Pustular Psoriasis |
5.9% |
| Encephalitis Herpes |
3.9% |
| Erysipelas |
3.9% |
| Haemorrhage Subcutaneous |
3.9% |
| Injury |
3.9% |
| Muscle Contractions Involuntary |
3.9% |
| Nausea |
3.9% |
| Orthostatic Hypotension |
3.9% |
| Pancreatitis Acute |
3.9% |
| Psoriatic Arthropathy |
3.9% |
| Renal Failure Acute |
3.9% |
| Sensory Disturbance |
3.9% |
|
| Interacting |
| Menopause |
50.0% |
| Osteoporosis |
50.0% |
|
| Endometrial Cancer |
100.0% |
|
